APC Antibody (Ali 12-28) - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NB100-667
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Human
Applications
Validated:
ELISA, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunoprecipitation
Cited:
Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # Ali 12-28
Format
BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
N-terminal APC-MBP fusion protein
Localization
Cytoplasmic and Nuclear
Specificity
Ali 12-28 detects both normal and mutant-truncated forms of the APC.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for APC Antibody (Ali 12-28) - BSA Free
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
20 ug/ml
Immunohistochemistry
1:10-1:500
Immunoprecipitation
1:10-1:500
Application Notes
This antibody has been used routinely for Western blotting on colon cell line HCT116, SW480 and SW837 extracts. Use in Immunohistochemistry-paraffin reported in scientific literature (Awadalla A et al).
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: APC
Long Name
Adenomatosis Polyposis Coli
Alternate Names
DP2, DP3, FPC, GS, Min
Gene Symbol
APC
UniProt
Additional APC Products
Product Documents for APC Antibody (Ali 12-28) - BSA Free
Product Specific Notices for APC Antibody (Ali 12-28) - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...